股浅动脉硬化闭塞症腔内治疗效果分析

Efficacy of endovascular treatment in patients with superficial femoral artery occlusive disease

目的评估股浅动脉硬化性闭塞症腔内治疗的临床疗效。方法前瞻性纳入我院从2012年4月至2013年5月26例SFA闭塞性病变患者,对腔内治疗效果进行分析。结果 26例患者(共26条患肢)均行球囊扩张术+支架植入术,技术成功率100%。ABI术前0.28±0.24,术后0.81±0.12,临床成功率80.8%。术中并发症1例(3.8%),术后并发症7例(26.9%)。患者均获得随访,平均随访时间(10.7±2.9)个月。术后1、3、6、12个月的一期通畅率分别为(96.15±3.77)%、(92.22±5.28)%、(88.04±6.49)%、(88.04±6.49)%,术后1、3、6、12个月的二期通畅率分别为(100.00±0.00)%、(96.15±3.77)%、(96.15±3.77)%、(96.15±3.77)%,术后1、3、6、12个月的保肢率分别为(92.31±5.23)%、(88.46±6.27)%、(88.46±6.27)%、(81.09±9.10)%,术后1、3、6、12个月的累积生存率分别为(100.00±0.00)%、(96.15±3.77)%、(85.62±7.08)%、(77.26±9.55)%。结论SFA闭塞性病变行腔内治疗的技术成功率及安全性均较高,短期通畅率较为理想。

Objective To evaluate the efficacy and salty of endovascular treatment for superficial femoral artery occlusive disease. Methods The study was a prospective, single-center study that enrolled 26 patients with symptomatic superficial femoral artery occlusive disease from April 2012 to May 2013. Their clinical results and follow-up data were retrospectively reviewed. Results All the 26 patients（26 lower limbs） were treated with endovascular intervention. Technical success rate was 100%. Mean ABIs were 0.28±0.24 and 0.81±0.12 before and after procedure. Clinical success rate was 80.8%. The complication occurred in one case（3.8%） in the operation and 7 cases（26.9%） after operation. Mean time of follow up was 10.7±2.9months. At 1,3,6 and 12 months after surgery, the primary patency rates were（96.15 ±3.77）%,（92.22 ±5.28）%,（88.04 ±6.49）% and（88.04 ±6.49）%, respectively. The secondary patency rates were（100.00 ±0.00）%,（96.15±3.77）%,（96.15±3.77）% and（96.15±3.77）%, respectively. The limb salvage rates were（92.31 ±5.23）%,（88.46% ±6.27）%,（88.46 ±6.27）% and（81.09% ±9.10）%, respectively. The cumulative survival rates were（100.00 ±0.00）%,（96.15 ±3.77）%,（85.62 ±7.08）% and（77.26 ±9.55）%, respectively.Conclusion The endovascular treatment is a safe and efficacious method for patients with superficial femoral artery occlusive disease. Its short-term efficacy is satisfactory.